Published in Vopr Virusol on December 16, 2011
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. J Prev Med Hyg (2014) 0.81
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design. Med Res Rev (2016) 0.80
Progress of small molecular inhibitors in the development of anti-influenza virus agents. Theranostics (2017) 0.75
Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments. Pharmaceuticals (Basel) (2011) 0.75
DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94
Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89
Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82
Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81
[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80
[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
[In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.79
[In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus]. Antibiot Khimioter (2010) 0.78
Role of the C-terminal fragment of human transthyretin in abnormal fibrillogenesis. Biochemistry (Mosc) (2006) 0.78
[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)]. Antibiot Khimioter (2008) 0.78
[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78
[Effect of the antiviral drug Ingaviruin on intracellular transformations and import into the nucleus of influenza A virus nucleocapsid protein]. Vopr Virusol (2011) 0.78
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77
[In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus]. Vopr Virusol (2012) 0.77
[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
[Effect of a combination of glutamyl-tryptophan and glycyrrhizic acid on the course of acute infection caused by influenza (H3H2) virus in mice]. Vopr Virusol (2012) 0.77
[In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009]. Antibiot Khimioter (2009) 0.77
[Use of cyto-differentiating agents in oncology]. Vopr Onkol (2006) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res (2003) 0.77
[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)]. Antibiot Khimioter (2008) 0.76
[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76
[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76
Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76
[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76
[The anti-viral activity of the complex glycyrrhizic acid-alpha-glutamyl-tryptophan against experimental lethal influenza infection in white mice caused by oseltamivir-resistant strain of the virus]. Vopr Virusol (2014) 0.75
[Antiviral effect of Ingavirin against seasonal influenza virus A/H1N1 in MDCK cell culture]. Antibiot Khimioter (2009) 0.75
[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol (2007) 0.75
[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. Antibiot Khimioter (2010) 0.75
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75
[Studying the effect of antioxidants and/or antihypoxants on cell cultures under conditions of cytotoxic action of rimantadine]. Eksp Klin Farmakol (2007) 0.75
[Compatibility of mitochondrial ribosomes with matrix RNA of nuclear origin]. Dokl Akad Nauk SSSR (1973) 0.75
[Determination of nucleotide sequences of Russian isolates of delta hepatitis virus]. Mol Gen Mikrobiol Virusol (1997) 0.75
[Effect of homologous nuclear RNA and infectious RNA of the Venezuelan equine encephalitis virus on the biosynthesis of RNA and protein in isolated rat liver mitochondria]. Biokhimiia (1974) 0.75
[Molecular mechanisms of selecting influenza virus strains by signs of drug resistance]. Dokl Akad Nauk SSSR (1991) 0.75
[Lymphokine-like activity in a culture of cells of the embryonal human brain and in the cerebrospinal fluid]. Fiziol Zh SSSR Im I M Sechenova (1988) 0.75
[Electron transport chain in the isolated nuclei and nuclear membranes of the rat liver]. Biokhimiia (1974) 0.75
[Replication of infectious viral RNA in isolated mitochondria. 1. Penetration of vital RNA into mitochondria and its effect on mitochondrial synthesis]. Vopr Virusol (1972) 0.75
[Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
Origin of the mitochondrial RNA of animal tissues. 2. Hybridization with nuclear DNA. Mol Biol (1974) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[Isolation of an individual mRNA from mitochondria, its reverse transcription and characteristics of the complementary DNA]. Dokl Akad Nauk SSSR (1978) 0.75
[Polyadenylic acid sequence in viral RNA]. Vopr Virusol (1976) 0.75
[Isolation and cloning of gene for hepatitis delta antigen. The use of recombinant antigen for serodiagnosis of delta infection]. Mol Gen Mikrobiol Virusol (1998) 0.75
[The effect of oxygen free radicals on the viability of strains of Saccharomyces with various levels of expression of the metallothionein gene]. Dokl Akad Nauk SSSR (1989) 0.75
[The role of influenza virus hemagglutinin in blood anticoagulation processes]. Vopr Virusol (1997) 0.75
[The origin of mitochondrial RNA in animal tissues. 4. Post-transcriptional RNA modification and polyribosome formation in isolated mitochondria]. Mol Biol (Mosk) (1976) 0.75
[The molecular mechanism of the action of antiviral preparations in the adamantane series]. Vestn Ross Akad Med Nauk (1993) 0.75
[Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[An analysis of the potential areas of recombination in the hemagglutinin genes of animal influenza viruses in relation to their adaptation to a new host--man]. Vopr Virusol (1994) 0.75
[Physicochemical characteristics of the products of virus-specific syntheses in isolated mitochondrial]. Dokl Akad Nauk SSSR (1973) 0.75
[Oligomeric forms of recombinant interleukin-2]. Biokhimiia (1991) 0.75
[Properties of thermostable HtpR-mutant of Escherichia coli]. Mol Gen Mikrobiol Virusol (1988) 0.75
[Interleukin-2 and cancer immunotherapy]. Vopr Onkol (1989) 0.75
[Detection of nucleotide sequences specific for retroviruses in Saccharomyces cells]. Genetika (1987) 0.75
[The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol (1994) 0.75
[Regulation of expression of the htpR gene in Escherichia coli]. Mol Biol (Mosk) (1987) 0.75
[Anti-HIV activity of complex isoborneol ethers]. Dokl Akad Nauk (1992) 0.75
[Antiviral activity of fullerene (60)C complexed with poly(N-vinylpyrrolidone)]. Dokl Akad Nauk (1998) 0.75
[Molecular chaperones: new proteins--new functions]. Mol Biol (Mosk) (1992) 0.75
No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses. Dokl Biol Sci (2007) 0.75
[Immunomorphological changes in the mouse brain after intracerebral administration of a neurotropic strain of influenza virus]. Biull Eksp Biol Med (1991) 0.75
[Actinomycin D binding with the DNA of some transplantable tumors]. Dokl Akad Nauk SSSR (1971) 0.75
[Polymorphism of current human influenza A and B virus population]. Vestn Ross Akad Med Nauk (1994) 0.75
[Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[The effective use of superoxide dismutase from human erythrocytes in the late stages of experimental influenza infection]. Vopr Virusol (1992) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75